Janus Henderson Investors US’s DexCom DXCM Stock Holding History

Janus Henderson Investors US’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$339M	Buy	16,007,884 +1,744,648	+12%	+$34.1M	0.28%	98
2016 Q4	$213M	Buy	14,263,236 +7,119,892	+100%	+$126M	0.18%	161
2016 Q3	$156M	Buy	7,143,344 +242,472	+4%	+$5.4M	0.13%	211
2016 Q2	$137M	Buy	6,900,872 +6,539,272	+1,808%	+$111M	0.12%	237
2016 Q1	$6.14M	Sell	361,600 -221,600	-38%	-$3.7M	0.01%	747
2015 Q4	$11.9M	Buy	583,200 +187,200	+47%	+$3.9M	0.01%	681
2015 Q3	$8.5M	Buy	+396,000	New	+$8.84M	0.01%	739

Other funds holding DXCM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Janus Henderson Investors US's DXCM Position: Q1 2017 in Review

Janus Henderson Investors US increased its DexCom (DXCM) stake by 12% in Q1 2017, buying an estimated $34.1M and bringing the position to 16,007,884 shares worth $339M. The position accounts for 0.28% of the portfolio, ranked #98.

Janus Henderson Investors US first reported a position in DXCM in Q3 2015 and has held it in 7 quarters since. 321 funds tracked by Wall St. Rank hold DXCM as of Q1 2017.

Janus Henderson Investors US held 16,007,884 shares of DexCom worth $339M as of Q1 2017.
Janus Henderson Investors US bought 1,744,648 DexCom shares in Q1 2017, an estimated $34.1M.
DexCom made up 0.28% of Janus Henderson Investors US's portfolio in Q1 2017, its #98 holding.
Janus Henderson Investors US first reported a position in DexCom in Q3 2015 and has held it in 7 quarters since.
321 funds tracked by Wall St. Rank held DexCom as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.